Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
Tokyo Court to rule on Fortis arm IHH and Daiichi Sankyo disputeA significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...
29 Apr, 2026, 12.20 AM IST
IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
29 Apr, 2026, 12.06 AM IST
Despite litigation, IHH says it is focused on key milestones for FortisMalaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Jap...
28 Apr, 2026, 12.05 PM IST
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
27 Apr, 2026, 02.24 PM IST
Japan issues advisory for northern coastal areas for slightly increased risk of mega-quakeJapan has issued an advisory for its northern coast. This follows a powerful earthquake earlier today. There is a small chance of a mega-qu...
20 Apr, 2026, 06.37 PM IST
IndiaFirst deal with BNP Cardif hits a UBI pact hurdleIndiaFirst Life's proposed stake sale to BNP Paribas Cardif is delayed. Union Bank of India has exited its corporate agency tie-up with Ind...
08 Apr, 2026, 06.07 AM IST
Fortis Open Offer: Daiichi Sankyo's 'misleading' statements continue to damage interests, says NTKIHH Healthcare's subsidiary, NTK, accuses Daiichi Sankyo of damaging its interests through misleading statements regarding the Fortis Healt...
29 May, 2025, 08.47 PM IST
IHH Healthcare claims 20 bn yen damages from Daiichi Sankyo for interference in Fortis Healthcare dealNorthern TK Venture Pte Ltd (NTK), a unit of Malaysia-based IHH Healthcare, has filed a lawsuit against Daiichi Sankyo in Tokyo District Co...
15 Nov, 2023, 01.06 AM IST
Fortis to respond to Daiichi’s objections to SRL demergerThe tribunal issued notice to Fortis on Daiichi’s application to intervene in the demerger on Friday, said lawyers. Fortis sought the tribu...
08 Jul, 2017, 01.26 AM IST
Ranbaxy, Daiichi Sankyo to collaborate in Brazil to expand businessIn Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil.
18 Apr, 2013, 04.00 AM IST
- Daiichi Sankyo and Ranbaxy Launch hybrid business in Venezuela
Daiichi Sankyo & Ranbaxy announced that Daiichi Sankyo Venezuela would begin marketing Ranbaxy products in Venezuela as part of hybrid busi...
20 Jun, 2012, 03.55 PM IST
- Ranbaxy to sell Daiichi Sankyo product in Malaysia
Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia.
21 Dec, 2011, 03.03 PM IST
- Ranbaxy Laboratories to sell Daiichi Sankyo's products in Italy
Ranbaxy Laboratories and its parent firm Daiichi Sankyo said they have entered into a partnership to distribute the Japanese firm's product...
04 Oct, 2011, 04.56 PM IST
- Ranbaxy, Daiichi Sankyo to expand business in Mexico
The two cos will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico before end of 2011.
02 Aug, 2011, 02.40 PM IST
- Daiichi to use Ranbaxy network to sell products in Singapore
Ranbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...
01 Mar, 2011, 06.08 PM IST
- Ranbaxy transfers new drug discovery unit to Daiichi Sankyo
Ranbaxy Laboratories on Friday said it has transferred its new drug discovery research unit (NDDR) to Daiichi Sankyo India Pharma.
02 Jul, 2010, 04.12 PM IST